Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-01-2024 | Campylobacter | Case report

Colistin/Gentamicin/Meropenem

Acquired drug resistance and drug intolerance

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Bonilla-Moreno M, et al. Development of Meropenem Resistance in a Multidrug-Resistant Campylobacter coli Strain Causing Recurrent Bacteremia in a Hematological Malignancy Patient. Antimicrobial Agents and Chemotherapy 67: No. 11, Nov 2023. Available from: URL: https://dx.doi.org/10.1128/aac.00272-23 Bonilla-Moreno M, et al. Development of Meropenem Resistance in a Multidrug-Resistant Campylobacter coli Strain Causing Recurrent Bacteremia in a Hematological Malignancy Patient. Antimicrobial Agents and Chemotherapy 67: No. 11, Nov 2023. Available from: URL: https://​dx.​doi.​org/​10.​1128/​aac.​00272-23
Metadata
Title
Colistin/Gentamicin/Meropenem
Acquired drug resistance and drug intolerance
Publication date
01-01-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-52590-1

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Multiple drugs

Case report

Elasomeran

Case report

Methotrexate

Case report

Multiple drugs